The 2026 elections have concluded, and the results mark a potential turning point for healthcare policy in the United States. As voters expressed deep concerns over affordability, a new dynamic is emerging in Congress that could fundamentally alter the landscape—particularly regarding the role of corporate entities in medicine.
A Changing Guard in Congress
One of the most notable outcomes of this election cycle is the increased representation of medical professionals in federal office. For the first time since 1938, the U.S. Senate will include a practicing physician who identifies as a Democrat, following the election of Dr. Annie Andrews. This shift suggests that the voices of frontline providers, intimately familiar with the frustrations of the current system, will have a more direct seat at the table when crafting future health policy . npr.org
The Corporate Takeover: ERs and Telehealth
While legislative change is on the horizon, the reality on the ground remains challenging. Aggressive acquisition of emergency room staffing groups and digital health platforms by private equity (PE) and venture capital (VC) firms continues to reshape care.
In the telehealth sector, platforms aimed at dietitians and other specialists are frequently criticized for prioritizing corporate margins over clinician autonomy and patient-centered care. Resources like The Liberated Clinician highlight the "dark side" of this model, where rapid scaling often leads to standardized, high-volume requirements that clash with the individualized, value-based care clinicians strive to provide . theliberatedclinician.com
The Impact on Clinicians and Care
This corporate shift has profound consequences for the healthcare workforce:
Compensation Disparity: Frontline clinicians—including doctors, nurses, and dietitians—often find their take-home pay to be only a small fraction of the total billable amount generated by their clinical work. The remainder is frequently absorbed by corporate management as overhead and profit.
Devaluation of Outcomes: The corporate business model often incentivizes volume over quality. When success is measured by the number of patient encounters, there is less incentive to pursue long-term, value-based care that leads to better patient outcomes.
What’s Next?
With the Democratic party aiming to address these systemic issues, we are seeing a push for more robust oversight. Legislative efforts like the Stop Corporate Takeovers Of Physicians Act of 2026 aim to establish federal bans on the corporate practice of medicine and create stricter guardrails on how management firms interact with physician platforms . legal500.com
As the new Congress takes shape, the debate over whether healthcare should be run primarily for corporate profit or patient wellness will likely define the next chapter of health policy.
For more on how the election is shaping the conversation, see recent coverage on the changing legislative landscape npr.org and the broader scrutiny of health-care deals . news.bloomberglaw.com
